Mark J Walker — ASN Events

Mark Walker

University of Queensland, QLD, Australia

This delegate is presenting an abstract at this event.

Professor Mark Walker is the Director of the Australian Infectious Disease Research Centre. Prof. Walker’s research focuses on the mechanism by which the group A streptococcus causes invasive disease, with the aim of developing GAS vaccines.

Presentations this author is a contributor to:

Detection of the hypervirulent chimeric emm4 lineage in Australia (#233)

5:30 PM

Phoebe K Shaw

Poster Session 2

New insights into the regulatory networks that control streptococcal superantigen production (#205)

5:30 PM

Stephan Brouwer

Poster Session 2

Construction of isogenic M1_UK mutants lacking scarlet fever-associated exotoxins (#242)

5:30 PM

Jasmine Wells

Poster Session 2

Investigating correlates of protection in the non-human primate model of pharyngitis by comparison of Combo#5 vaccines adjuvanted with Alum and SMQ (#173)

5:30 PM

Steven J Hancock

Poster Session 1

The Combo#5 mRNA-LNP Group A Streptococcus vaccine generates robust memory CD4⁺ and CD8⁺ effector T cells in mice. (118586)

11:27 AM

Rhiannon A Bolton

Plenary 11 - Lancefield Time Machine - The Shape of Things to Come

Mark Walker

University of Queensland, QLD, Australia

Detection of the hypervirulent chimeric emm4 lineage in Australia (#233)

New insights into the regulatory networks that control streptococcal superantigen production (#205)

Construction of isogenic M1UK mutants lacking scarlet fever-associated exotoxins (#242)

Investigating correlates of protection in the non-human primate model of pharyngitis by comparison of Combo#5 vaccines adjuvanted with Alum and SMQ (#173)

The Combo#5 mRNA-LNP Group A Streptococcus vaccine generates robust memory CD4+ and CD8+ effector T cells in mice. (118586)

Contact Mark Walker

Login

Construction of isogenic M1_UK mutants lacking scarlet fever-associated exotoxins (#242)

The Combo#5 mRNA-LNP Group A Streptococcus vaccine generates robust memory CD4⁺ and CD8⁺ effector T cells in mice. (118586)